ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZurichBEO Therapeutics AG
BEO Therapeutics AG Logo
Verified· 2 sources

BEO Therapeutics AG

Summary

About the company

BEO Therapeutics AG develops oral microbiome therapies to counteract diseases caused by metabolic waste products, such as gouty arthritis and (cardio-)metabolic disorders. The company focuses on QPS‑designated bacteria to rebalance the gut microbiome and is evaluating BEO 001 in phase 1/2 clinical trials in patients with hyperuricemia.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered2
Oral microbiome therapies
Oral microbiome therapies for the treatment of diseases through metabolic waste products, including gouty arthritis and cardiometabolic conditions; chronic use, rebalancing the gut microbiome and urate metabolism.
Clinical development of BEO 001
Clinical development of BEO 001 with two Phase 1/2 studies in more than 100 patients with hyperuricemia to evaluate safety, mechanism of action and efficacy.
Comparisons

BEO Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank BEO Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of BEO Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hermetschloostrasse 77
8048 Zurich

At a glance

Legal form
Corporation
UID
CHE-230.398.607
Founded
2019 · 7 years
Last commercial register change
March 17, 2025
Employees
1 to 10

Knowledge

No knowledge articles yet

Once BEO Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

SA
Stallergenes AG
Dietlikon
CA
CUTISS AG
Schlieren
ET
Endogena Therapeutics AG
Zurich
MT
Memo Therapeutics AG
Schlieren
VP
Vifor Pharma Management AG
Glattbrugg
VA
Vaccentis AG
Zurich
DT
Denali Therapeutics CH GmbH
Zurich
FH
Future Health Pharma GmbH
Wetzikon Zh 1